Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
521 1 |
Ultima descărcare din IBN: 2020-07-06 09:57 |
SM ISO690:2012 DUMBRAVA, Vlada-Tatiana, HOTINEANU, Vladimir, HOTINEANU, Adrian, TARAN, Natalia, LUPAŞCO, Iulianna. Managementul pacienților cu transplant hepatic: indicații și contraindicații pentru transplant hepatic. In: Sănătate Publică, Economie şi Management în Medicină , 2013, nr. 5(50), pp. 113-117. ISSN 1729-8687. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Sănătate Publică, Economie şi Management în Medicină | ||||||
Numărul 5(50) / 2013 / ISSN 1729-8687 /ISSNe 2587-3873 | ||||||
|
||||||
Pag. 113-117 | ||||||
|
||||||
Descarcă PDF | ||||||
Rezumat | ||||||
According to the WHO, over the past 20 years, mortality from cirrhosis is growing continuously. In countries where the economy is well-developed, cirrhosis is one of the six primary causes of death. In Moldova cirrhosis is considered the 3rd cause of death of liver mortality annually. Hepatocellular carcinoma can be detected in patients with cirrhosis 1.5-5% annually. The incidence of HCC is over 600,000 new cases/year, in continuous grow both in Europe and America. Currently liver transplantation is the established treatment of end-stage liver cirrhosis, hepatocellular carcinoma and fulminant hepatic failure. The progress in surgical technique, immunosuppression and post-transplant management led to a remarkable increase in the survival of the liver graft receptors, which currently reaches 85-90% at 1 year, 7076% at 5 years and 60% at 10 years post transplantation. |
||||||
Cuvinte-cheie transplant, liver cirrhosis, hepatocellular carcinoma, selection criteria, MELD score, PELD score, трансплант, цирроз печени, гепатоцеллюлярная карцинома, критерии отбора, скор MELD, скор PELD |
||||||
|